Showing 1-10 of 32 results for "".

• “Turn-Key” Hair Restoration Requires Caution: The Specialist's Perspective

  https://modernaesthetics.com/ma-issues-index/2019-july-aug/turn-key-hair-restoration-requires-caution-the-specialists-perspective/34023/
  Surgeons must protect their role and establish their expertise now and for the future.
  • Text
• Jeffrey Epstein, MD
  https://modernaesthetics.com/profiles/jeffrey-epstein-md/LqJGVB/
• Jeffrey Epstein, MD, FACS, FISHRS
  https://modernaesthetics.com/profiles/jeffrey-epstein-md-facs-fishrs/j5eaMx/

• MATV News Extra: Daxxify Q&A with Dr. Jeffrey Dover

  https://modernaesthetics.com/series/matv-news/matv-news-extra-daxxify-qa-with-dr-jeffrey-dover/33704/
  The FDA has approved Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) for injection for the temporary improvement of moderate to severe glabellar lines in adults. Dermatologists and clinical trial investigator Jeffrey Dover, MD sat down with MATV News to share insights into the SAKURA Phase
  • Video

• MATV News: Revance’s Daxxify Approved; ASPS Data Show Cosmetic Surgery Booming; DREAM Initiative Supports Residency Curriculum for Advancing Racial Equity

  https://modernaesthetics.com/series/matv-news/matv-news-revances-daxxify-approved-asps-data-show-cosmetic-surgery-booming-dream-initiative-supports-residency-curriculum-for-advancing-racial-equity/33703/
  Revance Therapeutics’ Daxxify (daxibotulinumtoxinA-lanm) wins FDA approval for the temporary improvement of moderate to severe glabellar lines in adults. Clinical trial investigator Jeffrey Dover, MD discusses Daxxify’s unique Peptide Exchange Technology (PXT) and long-lasting effects. New data from
  • Video

• Cutera’s AviClear

  https://modernaesthetics.com/topics/energy-based-devices/cuteras-aviclear/35163/
  • Text

• Profiles in Innovation: David E. Kent, MD

  https://modernaesthetics.com/topics/energy-based-devices/profiles-in-innovation-david-e-kent-md/34909/
  • Text

• Empathy and Transactional Medicine: Improving Patient and Physician Outcomes

  https://modernaesthetics.com/ma-issues-index/2020-jan-feb/empathy-and-transactional-medicine-improving-patient-and-physician-outcomes/34862/
  For each individual patient, the patient-physician interaction is unique and requires vulnerability, exposure, and discomfort.
  • Text

• In Focus: Inclusion

  https://modernaesthetics.com/ma-issues-index/2020-jan-feb/in-focus-inclusion/34859/
  • Text

• Pro Tips: Starting Your Private Practice

  https://modernaesthetics.com/ma-issues-index/2023-sept-oct/pro-tips-starting-your-private-practice/35315/
  Expert insights on opening, operating and ultimatly succeeding in your private aesthetics practice.
  • Text

• Prev
• 1
• 2
• 3
• 4
• Next